TNYA
TNYA
NASDAQ · Biotechnology

Tenaya Therapeutics Inc

$0.81
+0.06 (+8.20%)
As of Feb 8, 2:06 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 59.14M 52.95M 62.98M
Net Income 4.93M 4.47M 5.16M
EPS
Profit Margin 8.3% 8.4% 8.2%
Rev Growth +23.4% +5.7% +6.5%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 55.11M 53.41M 65.28M
Total Equity 120.13M 125.92M 131.81M
D/E Ratio 0.46 0.42 0.50
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.59M 4.86M 6.72M
Free Cash Flow 3.58M 3.18M 3.67M